Investment archive

Investment feed — page 142

Back to latest investments

The 81 Collection announces inaugural $41M Fund I for hard-industry startups

The 81 Collection announces inaugural $41M Fund I for hard-industry startups

Historical fund announcement, December 20, 2022, not new 2026 capital. Firm described a $41M inaugural fund targeting pre-seed and Seed startups innovating in manufacturing, construction and other capital-intensive industries, with initial $500K–$1.5M cheques. More than two-thirds came from current/former industry founders and DNS Capital was an institutional backer. Exact legal first/final close date not separately confirmed by the announcement.

Protect AI raises $13.5M seed

Protect AI raises $13.5M seed

Early seed investors include boldstart, Acrew and Pelion; amount later confirmed retrospectively. Historical financing/transaction for protect-ai. Source: https://boldstart.vc/companies/protect-ai/

Pathway secures reported $4.5M pre-seed from Inovo and Market One Capital

Pathway secures reported $4.5M pre-seed from Inovo and Market One Capital

December 2022 coverage describes a $4.5M pre-seed co-led by Inovo and Market One Capital, also reported as €4.2M. This early live-data software funding preceded Pathway's BDH architecture research.

Galvanize announces $100M Series B alongside merger of three ATP-incubated companies

Galvanize announces $100M Series B alongside merger of three ATP-incubated companies

Historical $100M Series B announced September 15, 2022. Deal accompanied the combination of Gala Therapeutics, Galaxy Medical and Galvanize Therapeutics; it is not a new 2026 round.

Nanopath closes $10M Series A for rapid women's-health diagnostics

Nanopath closes $10M Series A for rapid women's-health diagnostics

Issuer-confirmed historical August 9, 2022 $10M Series A co-led by Norwest and the SV Health Investors Medtech Convergence Fund. Not an additional 2026 round. Intended to advance amplification-free point-of-care biosensing. Equity valuation undisclosed.

Flashpoint VC III announces $102M close

Flashpoint VC III announces $102M close

Original manager-issued wire reports $102M close inclusive of $20M Széchenyi Funds LP commitment; republished archive headline says $105M, a conflict requiring caution.

Sanyou Bio completes Series B+ financing led by Huatai Zijin-affiliated funds in 2022

Sanyou Bio completes Series B+ financing led by Huatai Zijin-affiliated funds in 2022

Issuer announced a distinct Series B+ close on August 2, 2022, led by Huatai Zijin-linked funds Zijin Hongyun and Huatai Guoxin, with LH Ventures and other participants. Original release provides a broad non-USD/EUR amount range but no precise USD/EUR conversion; structured public amount remains undisclosed.

Upfront announces continuation vehicle above $175M

Upfront announces continuation vehicle above $175M

Upfront announced more than $175M for a continuation vehicle on July 26, 2022. This is a lower-bound commitment figure, separate from its new-company funds.

Upfront announces $200M Growth III

Upfront announces $200M Growth III

Upfront announced $200M of commitments for Growth III on July 26, 2022, separate from Fund VII and a continuation vehicle.

Upfront closes $280M Fund VII

Upfront closes $280M Fund VII

Upfront announced $280M for Fund VII on July 26, 2022. It is distinct from the simultaneously announced growth and continuation vehicles.

Collaborative Fund closes the $200M Collab SOS fund

Collaborative Fund closes the $200M Collab SOS fund

Collaborative Fund closes the $200M Collab SOS fund